Metabolic syndrome (MetS) is not a disease; it is a syndrome. MetS is a cluster of interrelated risk factors for cardiovascular disease (CVD) and type 2 diabetes. These risk factors include abdominal obesity, elevated triglycerides, reduced high density lipoprotein cholesterol (HDL-C), dysglycemia and hypertension (1). The syndrome was first described as early as 1923 but achieved modern recognition when it was identified as Syndrome X by Reaven in 1988. He noted that several